Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00776958 · ClinicalTrials.gov registry record
Lynne Cohen Consortium Project: Multi-Center Database/Registry
A clinical trial of Breast Cancer and Ovarian Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 176
- Enrollment target
- 4
- Study locations
NCT00776958 is a study of Breast Cancer and Ovarian Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 176 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00776958, a study of Breast Cancer and Ovarian Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
- 4
- Study locations
Study Summary
Goals of this registry: 1.1 To collect and store very limited demographic information (age, birthdate, race and ethnicity), limited cancer risk and breast and ovarian disease history, as well as limited family history of breast and ovarian cancer on patients who are at risk of breast or ovarian cancer or who have had a diagnosis of either cancer, 1.2 To make available summary information (in an anonymous form) regarding the subjects in this registry to Consortium members, and other investigators, who can use these data to plan research projects and evaluate the feasibility of such projects, 1.3 To make available summary information (number of new patients seen in the clinic, number of mutations, number of preventive surgeries, average age of patients seen) to the Lynne Cohen Foundation for Ovarian Cancer Research, in order to document the numbers of subjects who utilize their supported clinics.
Conditions Studied
Interventions
- OTHER Questionnaire
Study Locations (4)
Alabama
- University of Alabama, Birmingham/Department of OB/GYN - Birmingham
California
- USC/Norris Comprehensive Cancer Center - Los Angeles
New York
- NYU Cancer Institute - New York
Texas
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2008-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00776958
The ClinicalTrials.gov registry entry for NCT00776958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00776958 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, California, New York.
Frequently Asked Questions
What is clinical trial NCT00776958 about?
NCT00776958 is a clinical study titled "Lynne Cohen Consortium Project: Multi-Center Database/Registry". Goals of this registry: 1.1 To collect and store very limited demographic information (age, birthdate, race and ethnicity), limited cancer risk and breast and ovarian disease history, as well as limited family history of breast and ovarian cancer on patients who are at risk of breast or ovarian can...
What is the current status of trial NCT00776958?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2008-07.
What conditions does trial NCT00776958 study?
This clinical trial studies the following conditions: Breast Cancer, Ovarian Cancer.
What interventions are being tested in trial NCT00776958?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT00776958?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00776958 being conducted?
This trial has 4 study locations across Alabama, California, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.